Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by b...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2009
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23506
- Acceso en línea:
- https://doi.org/10.1016/j.bbrc.2009.04.138
https://repository.urosario.edu.co/handle/10336/23506
- Palabra clave:
- HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_af53e7257cb4e33b49972075216b124b |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23506 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
d39495d0-c601-4370-a993-42b78fd63e7d-151721018-118e61850-2427-4a1d-aeaf-a88c5dea72e5-1b3ed2fba-3a5b-4e64-9896-4c6cae31683a-19e3ba9df-fe89-48fe-9521-cc8f452d56f5-12020-05-26T00:02:36Z2020-05-26T00:02:36Z2009A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by blocking the parasite's access to hepatic cells, and/or proteins involved in the development of this stage, amongst which are included the Liver Stage Antigen-1 (LSA-1) and the Sporozoite and Liver Stage Antigen (SALSA). Our studies have focused on the search for an association between the structure of high activity binding peptides (HABPs), including both conserved native and their modified analogues, and their ability to bind to the MHC Class II HLA-DR molecules during formation of the MHCII-peptide-TCR complex leading to inducing the appropriate immune response. These studies are part of a logical and rational strategy for developing multi-stage, multi-component, minimal subunit-based vaccines, mainly against the P. falciparum malaria. © 2009 Elsevier Inc. All rights reserved.application/pdfhttps://doi.org/10.1016/j.bbrc.2009.04.1380006291X10902104https://repository.urosario.edu.co/handle/10336/23506eng460No. 4455Biochemical and Biophysical Research CommunicationsVol. 384Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.384, No.4 (2009); pp. 455-460https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649150730&doi=10.1016%2fj.bbrc.2009.04.138&partnerID=40&md5=f675281f5f8f822763200d20c175c9ffAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHLA DR antigenLiver stage antigen 1Major histocompatibility antigen class 2Malaria vaccineParasite antigenPlasmodium falciparum malarial proteinProtozoal proteinSporozoite and liver stage antigenT lymphocyte receptorUnclassified drugAnimal cellAnimal experimentAnimal modelAnimal tissueAntigen structureArticleCell invasionControlled studyHost parasite interactionImmune responseImmunogenicityLiver cellMalariaMonkeyNonhumanNucleotide sequencePlasmodium falciparumPriority journalSporozoiteAmino Acid SequenceAnimalsHLA-DR AntigensImmunizationLiverMalaria VaccinesMolecular Sequence DataPlasmodium falciparumProtozoan ProteinsPlasmodium falciparumHLA-dr?1* moleculesLSA-1MalariaMHCII-peptide-TCR complexSALSASubunitProtozoanSecondaryAntigensProtein StructureVaccinesStructural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteinsarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cifuentes, GladysVanegas, MagnoliaMartinez, Nora LorenaPirajan, CamiloPatarroyo, Manuel ElkinORIGINALStructural_characteristics_of_immunogeni.pdfapplication/pdf3220121https://repository.urosario.edu.co/bitstreams/40f8fd78-06f1-400a-bcab-4127ed89c4f7/download54d41f854a7d2d32829280ec220f30c7MD51TEXTStructural_characteristics_of_immunogeni.pdf.txtStructural_characteristics_of_immunogeni.pdf.txtExtracted texttext/plain31673https://repository.urosario.edu.co/bitstreams/43c18b5e-5379-4831-b6f1-5cdfa9049c6d/download1a97e73d416c5e9dc602bce1fc8cafcfMD52THUMBNAILStructural_characteristics_of_immunogeni.pdf.jpgStructural_characteristics_of_immunogeni.pdf.jpgGenerated Thumbnailimage/jpeg4966https://repository.urosario.edu.co/bitstreams/f5807c92-8846-4c43-babf-94e0fd4f11dd/download014a1d9b17608b027e725c4e3f02b365MD5310336/23506oai:repository.urosario.edu.co:10336/235062022-05-02 07:37:21.027854https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
title |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
spellingShingle |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins HLA DR antigen Liver stage antigen 1 Major histocompatibility antigen class 2 Malaria vaccine Parasite antigen Plasmodium falciparum malarial protein Protozoal protein Sporozoite and liver stage antigen T lymphocyte receptor Unclassified drug Animal cell Animal experiment Animal model Animal tissue Antigen structure Article Cell invasion Controlled study Host parasite interaction Immune response Immunogenicity Liver cell Malaria Monkey Nonhuman Nucleotide sequence Plasmodium falciparum Priority journal Sporozoite Amino Acid Sequence Animals HLA-DR Antigens Immunization Liver Malaria Vaccines Molecular Sequence Data Plasmodium falciparum Protozoan Proteins Plasmodium falciparum HLA-dr?1* molecules LSA-1 Malaria MHCII-peptide-TCR complex SALSA Subunit Protozoan Secondary Antigens Protein Structure Vaccines |
title_short |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
title_full |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
title_fullStr |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
title_full_unstemmed |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
title_sort |
Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins |
dc.subject.keyword.spa.fl_str_mv |
HLA DR antigen Liver stage antigen 1 Major histocompatibility antigen class 2 Malaria vaccine Parasite antigen Plasmodium falciparum malarial protein Protozoal protein Sporozoite and liver stage antigen T lymphocyte receptor Unclassified drug Animal cell Animal experiment Animal model Animal tissue Antigen structure Article Cell invasion Controlled study Host parasite interaction Immune response Immunogenicity Liver cell Malaria Monkey Nonhuman Nucleotide sequence Plasmodium falciparum Priority journal Sporozoite Amino Acid Sequence Animals HLA-DR Antigens Immunization Liver Malaria Vaccines Molecular Sequence Data Plasmodium falciparum Protozoan Proteins Plasmodium falciparum HLA-dr?1* molecules LSA-1 Malaria MHCII-peptide-TCR complex SALSA |
topic |
HLA DR antigen Liver stage antigen 1 Major histocompatibility antigen class 2 Malaria vaccine Parasite antigen Plasmodium falciparum malarial protein Protozoal protein Sporozoite and liver stage antigen T lymphocyte receptor Unclassified drug Animal cell Animal experiment Animal model Animal tissue Antigen structure Article Cell invasion Controlled study Host parasite interaction Immune response Immunogenicity Liver cell Malaria Monkey Nonhuman Nucleotide sequence Plasmodium falciparum Priority journal Sporozoite Amino Acid Sequence Animals HLA-DR Antigens Immunization Liver Malaria Vaccines Molecular Sequence Data Plasmodium falciparum Protozoan Proteins Plasmodium falciparum HLA-dr?1* molecules LSA-1 Malaria MHCII-peptide-TCR complex SALSA Subunit Protozoan Secondary Antigens Protein Structure Vaccines |
dc.subject.keyword.eng.fl_str_mv |
Subunit Protozoan Secondary Antigens Protein Structure Vaccines |
description |
A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by blocking the parasite's access to hepatic cells, and/or proteins involved in the development of this stage, amongst which are included the Liver Stage Antigen-1 (LSA-1) and the Sporozoite and Liver Stage Antigen (SALSA). Our studies have focused on the search for an association between the structure of high activity binding peptides (HABPs), including both conserved native and their modified analogues, and their ability to bind to the MHC Class II HLA-DR molecules during formation of the MHCII-peptide-TCR complex leading to inducing the appropriate immune response. These studies are part of a logical and rational strategy for developing multi-stage, multi-component, minimal subunit-based vaccines, mainly against the P. falciparum malaria. © 2009 Elsevier Inc. All rights reserved. |
publishDate |
2009 |
dc.date.created.spa.fl_str_mv |
2009 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:02:36Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:02:36Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.bbrc.2009.04.138 |
dc.identifier.issn.none.fl_str_mv |
0006291X 10902104 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23506 |
url |
https://doi.org/10.1016/j.bbrc.2009.04.138 https://repository.urosario.edu.co/handle/10336/23506 |
identifier_str_mv |
0006291X 10902104 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
460 |
dc.relation.citationIssue.none.fl_str_mv |
No. 4 |
dc.relation.citationStartPage.none.fl_str_mv |
455 |
dc.relation.citationTitle.none.fl_str_mv |
Biochemical and Biophysical Research Communications |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 384 |
dc.relation.ispartof.spa.fl_str_mv |
Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.384, No.4 (2009); pp. 455-460 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649150730&doi=10.1016%2fj.bbrc.2009.04.138&partnerID=40&md5=f675281f5f8f822763200d20c175c9ff |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/40f8fd78-06f1-400a-bcab-4127ed89c4f7/download https://repository.urosario.edu.co/bitstreams/43c18b5e-5379-4831-b6f1-5cdfa9049c6d/download https://repository.urosario.edu.co/bitstreams/f5807c92-8846-4c43-babf-94e0fd4f11dd/download |
bitstream.checksum.fl_str_mv |
54d41f854a7d2d32829280ec220f30c7 1a97e73d416c5e9dc602bce1fc8cafcf 014a1d9b17608b027e725c4e3f02b365 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1831928153066438656 |